Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for TEAD4
Z-value: 1.14
Motif logo
Transcription factors associated with TEAD4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TEAD4
|
ENSG00000197905.10 | TEAD4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TEAD4 | hg38_v1_chr12_+_2959870_2959953, hg38_v1_chr12_+_2959296_2959431 | -0.60 | 6.0e-23 | Click! |
Activity profile of TEAD4 motif
Sorted Z-values of TEAD4 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of TEAD4
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_-_91146195 | 35.61 |
ENST00000548218.1
|
DCN
|
decorin |
| chr17_-_31297231 | 20.58 |
ENST00000247271.5
|
OMG
|
oligodendrocyte myelin glycoprotein |
| chr12_-_91178520 | 18.63 |
ENST00000425043.5
ENST00000420120.6 ENST00000441303.6 ENST00000456569.2 |
DCN
|
decorin |
| chr19_+_9087061 | 17.75 |
ENST00000641627.1
|
OR1M1
|
olfactory receptor family 1 subfamily M member 1 |
| chr21_+_46458846 | 16.75 |
ENST00000417564.3
ENST00000651436.1 ENST00000400274.5 ENST00000457905.7 ENST00000466639.5 ENST00000435722.7 |
DIP2A
|
disco interacting protein 2 homolog A |
| chr5_-_42811884 | 16.30 |
ENST00000514985.6
ENST00000511224.5 ENST00000507920.5 ENST00000510965.1 |
SELENOP
|
selenoprotein P |
| chr3_+_101827982 | 15.99 |
ENST00000461724.5
ENST00000483180.5 ENST00000394054.6 |
NFKBIZ
|
NFKB inhibitor zeta |
| chr19_+_9185594 | 15.86 |
ENST00000344248.4
|
OR7D2
|
olfactory receptor family 7 subfamily D member 2 |
| chr2_+_200440649 | 15.75 |
ENST00000366118.2
|
SPATS2L
|
spermatogenesis associated serine rich 2 like |
| chr13_-_67230377 | 15.49 |
ENST00000544246.5
ENST00000377861.4 |
PCDH9
|
protocadherin 9 |
| chr3_-_18424533 | 14.92 |
ENST00000417717.6
|
SATB1
|
SATB homeobox 1 |
| chr13_-_67230313 | 14.89 |
ENST00000377865.7
|
PCDH9
|
protocadherin 9 |
| chr17_+_40062810 | 14.36 |
ENST00000584985.5
ENST00000264637.8 |
THRA
|
thyroid hormone receptor alpha |
| chr8_-_27258414 | 13.56 |
ENST00000523048.5
|
STMN4
|
stathmin 4 |
| chr17_-_68955332 | 13.11 |
ENST00000269080.6
ENST00000615593.4 ENST00000586539.6 ENST00000430352.6 |
ABCA8
|
ATP binding cassette subfamily A member 8 |
| chr14_-_106165730 | 12.32 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
| chr7_-_36985060 | 12.25 |
ENST00000396040.6
|
ELMO1
|
engulfment and cell motility 1 |
| chr1_-_158686700 | 12.05 |
ENST00000643759.2
|
SPTA1
|
spectrin alpha, erythrocytic 1 |
| chr8_-_27258386 | 11.96 |
ENST00000350889.8
ENST00000519997.5 ENST00000519614.5 ENST00000522908.1 ENST00000265770.11 |
STMN4
|
stathmin 4 |
| chr6_-_52840843 | 11.90 |
ENST00000370989.6
|
GSTA5
|
glutathione S-transferase alpha 5 |
| chr3_+_138348823 | 11.66 |
ENST00000475711.5
ENST00000464896.5 |
MRAS
|
muscle RAS oncogene homolog |
| chr2_-_136118142 | 11.60 |
ENST00000241393.4
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
| chr1_-_11848345 | 11.11 |
ENST00000376476.1
|
NPPA
|
natriuretic peptide A |
| chr4_+_153222402 | 10.76 |
ENST00000676335.1
ENST00000675146.1 |
TRIM2
|
tripartite motif containing 2 |
| chr6_-_46325641 | 10.60 |
ENST00000330430.10
ENST00000405162.2 |
RCAN2
|
regulator of calcineurin 2 |
| chrX_+_21374608 | 10.49 |
ENST00000644295.1
ENST00000645074.1 ENST00000645791.1 ENST00000643220.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr6_-_109009498 | 10.47 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
| chr17_+_49788672 | 10.47 |
ENST00000454930.6
ENST00000259021.9 ENST00000509773.5 ENST00000510819.5 ENST00000424009.6 |
KAT7
|
lysine acetyltransferase 7 |
| chr6_-_152168349 | 10.27 |
ENST00000539504.5
|
SYNE1
|
spectrin repeat containing nuclear envelope protein 1 |
| chr2_-_196068812 | 10.12 |
ENST00000410072.5
ENST00000312428.11 |
DNAH7
|
dynein axonemal heavy chain 7 |
| chr5_+_174045673 | 9.76 |
ENST00000303177.8
ENST00000519867.5 |
NSG2
|
neuronal vesicle trafficking associated 2 |
| chr2_-_89160329 | 9.54 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr14_-_106269133 | 9.29 |
ENST00000390609.3
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr16_+_30374794 | 9.17 |
ENST00000322861.12
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chrX_+_21374434 | 8.96 |
ENST00000279451.9
ENST00000645245.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chrX_+_21374288 | 8.96 |
ENST00000642359.1
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr6_-_152168291 | 8.85 |
ENST00000354674.5
|
SYNE1
|
spectrin repeat containing nuclear envelope protein 1 |
| chr4_-_39032343 | 8.76 |
ENST00000381938.4
|
TMEM156
|
transmembrane protein 156 |
| chr14_-_106593319 | 8.69 |
ENST00000390627.3
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr2_-_127220293 | 8.57 |
ENST00000664447.2
ENST00000409327.2 |
CYP27C1
|
cytochrome P450 family 27 subfamily C member 1 |
| chr2_-_178807415 | 8.36 |
ENST00000342992.10
ENST00000460472.6 ENST00000589042.5 ENST00000591111.5 ENST00000360870.10 |
TTN
|
titin |
| chrX_+_21374357 | 8.32 |
ENST00000643841.1
ENST00000379510.5 ENST00000425654.7 ENST00000644798.1 ENST00000543067.6 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr3_+_124094663 | 8.29 |
ENST00000460856.5
ENST00000240874.7 |
KALRN
|
kalirin RhoGEF kinase |
| chr7_+_77696423 | 8.08 |
ENST00000334955.13
|
RSBN1L
|
round spermatid basic protein 1 like |
| chr13_-_44437214 | 8.01 |
ENST00000622051.1
|
TSC22D1
|
TSC22 domain family member 1 |
| chr22_-_50085331 | 7.89 |
ENST00000395876.6
|
MLC1
|
modulator of VRAC current 1 |
| chr19_+_35138993 | 7.82 |
ENST00000612146.4
ENST00000589209.5 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr7_+_148133684 | 7.72 |
ENST00000628930.2
|
CNTNAP2
|
contactin associated protein 2 |
| chr2_+_90021567 | 7.66 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr1_+_160796157 | 7.62 |
ENST00000263285.11
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
| chr19_+_35139724 | 7.37 |
ENST00000588715.5
ENST00000588607.5 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr10_-_49762276 | 7.27 |
ENST00000374103.9
|
OGDHL
|
oxoglutarate dehydrogenase L |
| chr10_-_49762335 | 7.15 |
ENST00000419399.4
ENST00000432695.2 |
OGDHL
|
oxoglutarate dehydrogenase L |
| chr15_+_33968484 | 7.13 |
ENST00000383263.7
|
CHRM5
|
cholinergic receptor muscarinic 5 |
| chr4_-_148444674 | 7.10 |
ENST00000344721.8
|
NR3C2
|
nuclear receptor subfamily 3 group C member 2 |
| chr1_+_241532370 | 7.09 |
ENST00000366559.9
ENST00000366557.8 |
KMO
|
kynurenine 3-monooxygenase |
| chr4_+_70430487 | 7.03 |
ENST00000413702.5
|
MUC7
|
mucin 7, secreted |
| chr9_-_101487120 | 7.03 |
ENST00000374848.8
|
PGAP4
|
post-GPI attachment to proteins GalNAc transferase 4 |
| chr4_+_153222307 | 6.91 |
ENST00000675899.1
ENST00000675611.1 ENST00000674872.1 ENST00000676167.1 |
TRIM2
|
tripartite motif containing 2 |
| chr2_-_127811149 | 6.89 |
ENST00000322313.9
ENST00000393006.5 ENST00000409658.7 ENST00000436787.5 |
WDR33
|
WD repeat domain 33 |
| chr22_-_50085414 | 6.83 |
ENST00000311597.10
|
MLC1
|
modulator of VRAC current 1 |
| chr1_-_154956086 | 6.62 |
ENST00000368463.8
ENST00000368460.7 ENST00000368465.5 |
PBXIP1
|
PBX homeobox interacting protein 1 |
| chr9_-_15472732 | 6.52 |
ENST00000481862.1
|
PSIP1
|
PC4 and SFRS1 interacting protein 1 |
| chr8_+_24294044 | 6.47 |
ENST00000265769.9
|
ADAM28
|
ADAM metallopeptidase domain 28 |
| chr15_+_80441229 | 6.38 |
ENST00000533983.5
ENST00000527771.5 ENST00000525103.1 |
ARNT2
|
aryl hydrocarbon receptor nuclear translocator 2 |
| chr12_+_109116581 | 6.38 |
ENST00000338432.11
|
ACACB
|
acetyl-CoA carboxylase beta |
| chr14_-_106658251 | 6.33 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr12_+_12725897 | 6.28 |
ENST00000326765.10
|
APOLD1
|
apolipoprotein L domain containing 1 |
| chr10_-_60389833 | 6.21 |
ENST00000280772.7
|
ANK3
|
ankyrin 3 |
| chr11_-_59866478 | 6.20 |
ENST00000257264.4
|
TCN1
|
transcobalamin 1 |
| chr10_-_88952763 | 6.10 |
ENST00000224784.10
|
ACTA2
|
actin alpha 2, smooth muscle |
| chr3_+_138348592 | 6.10 |
ENST00000621127.4
ENST00000494949.5 |
MRAS
|
muscle RAS oncogene homolog |
| chr1_+_45551031 | 6.08 |
ENST00000481885.5
ENST00000471651.1 |
AKR1A1
|
aldo-keto reductase family 1 member A1 |
| chr2_-_60553558 | 6.06 |
ENST00000642439.1
ENST00000356842.9 |
BCL11A
|
BAF chromatin remodeling complex subunit BCL11A |
| chr3_+_138348570 | 6.06 |
ENST00000423968.7
|
MRAS
|
muscle RAS oncogene homolog |
| chr10_-_73651013 | 5.94 |
ENST00000372873.8
|
SYNPO2L
|
synaptopodin 2 like |
| chr17_+_4951758 | 5.87 |
ENST00000518175.1
|
ENO3
|
enolase 3 |
| chr5_-_10307821 | 5.73 |
ENST00000296658.4
|
CMBL
|
carboxymethylenebutenolidase homolog |
| chr16_+_33009175 | 5.69 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr2_-_60553618 | 5.60 |
ENST00000643716.1
ENST00000359629.10 ENST00000642384.2 ENST00000335712.11 |
BCL11A
|
BAF chromatin remodeling complex subunit BCL11A |
| chr5_+_140882116 | 5.57 |
ENST00000289272.3
ENST00000409494.5 ENST00000617769.1 |
PCDHA13
|
protocadherin alpha 13 |
| chrX_+_37780049 | 5.47 |
ENST00000378588.5
|
CYBB
|
cytochrome b-245 beta chain |
| chr20_-_23826721 | 5.46 |
ENST00000304725.3
|
CST2
|
cystatin SA |
| chr11_-_117876612 | 5.45 |
ENST00000584230.1
ENST00000526014.6 ENST00000584394.5 ENST00000614497.5 ENST00000532984.1 |
FXYD6
FXYD6-FXYD2
|
FXYD domain containing ion transport regulator 6 FXYD6-FXYD2 readthrough |
| chr11_+_46936710 | 5.43 |
ENST00000378618.6
ENST00000278460.12 ENST00000395460.6 ENST00000378615.7 |
C11orf49
|
chromosome 11 open reading frame 49 |
| chr1_-_156282799 | 5.40 |
ENST00000361813.5
|
SMG5
|
SMG5 nonsense mediated mRNA decay factor |
| chr5_+_180988840 | 5.39 |
ENST00000342868.7
|
BTNL3
|
butyrophilin like 3 |
| chr17_+_42458844 | 5.34 |
ENST00000393829.6
ENST00000537728.5 ENST00000343619.9 ENST00000264649.10 ENST00000585525.5 ENST00000544137.5 ENST00000589727.5 ENST00000587824.5 |
ATP6V0A1
|
ATPase H+ transporting V0 subunit a1 |
| chr4_-_185810894 | 5.24 |
ENST00000448662.6
ENST00000439049.5 ENST00000420158.5 ENST00000319471.13 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_-_10568571 | 5.22 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
| chr7_+_87934242 | 5.19 |
ENST00000413139.2
ENST00000412441.5 ENST00000683525.1 ENST00000398201.8 ENST00000265727.11 ENST00000398209.7 ENST00000684002.1 |
ADAM22
|
ADAM metallopeptidase domain 22 |
| chr12_+_68808143 | 5.18 |
ENST00000258149.11
ENST00000428863.6 ENST00000393412.7 |
MDM2
|
MDM2 proto-oncogene |
| chr8_+_54457927 | 5.18 |
ENST00000297316.5
|
SOX17
|
SRY-box transcription factor 17 |
| chr11_-_10568650 | 5.18 |
ENST00000256178.8
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
| chr2_+_1414382 | 5.17 |
ENST00000423320.5
ENST00000346956.7 ENST00000382198.5 |
TPO
|
thyroid peroxidase |
| chr1_+_241532121 | 5.15 |
ENST00000366558.7
|
KMO
|
kynurenine 3-monooxygenase |
| chr4_-_185395882 | 5.13 |
ENST00000505916.6
|
LRP2BP
|
LRP2 binding protein |
| chr3_+_189631373 | 5.07 |
ENST00000264731.8
ENST00000418709.6 ENST00000320472.9 ENST00000392460.7 ENST00000440651.6 |
TP63
|
tumor protein p63 |
| chr12_-_110920710 | 5.04 |
ENST00000546404.1
|
MYL2
|
myosin light chain 2 |
| chr4_-_88823165 | 5.02 |
ENST00000508369.5
|
FAM13A
|
family with sequence similarity 13 member A |
| chr19_-_3786363 | 5.00 |
ENST00000310132.11
|
MATK
|
megakaryocyte-associated tyrosine kinase |
| chr3_+_124094696 | 4.93 |
ENST00000360013.7
ENST00000684186.1 ENST00000684276.1 |
KALRN
|
kalirin RhoGEF kinase |
| chr4_-_47981535 | 4.91 |
ENST00000402813.9
|
CNGA1
|
cyclic nucleotide gated channel subunit alpha 1 |
| chr12_+_10307818 | 4.90 |
ENST00000350274.9
ENST00000336164.9 |
KLRD1
|
killer cell lectin like receptor D1 |
| chr8_-_69833338 | 4.89 |
ENST00000524945.5
|
SLCO5A1
|
solute carrier organic anion transporter family member 5A1 |
| chr15_+_81182579 | 4.87 |
ENST00000302987.9
|
IL16
|
interleukin 16 |
| chr19_+_57120043 | 4.82 |
ENST00000254181.8
ENST00000600940.1 |
USP29
|
ubiquitin specific peptidase 29 |
| chr5_-_139439488 | 4.82 |
ENST00000302060.10
|
DNAJC18
|
DnaJ heat shock protein family (Hsp40) member C18 |
| chr2_-_86337617 | 4.72 |
ENST00000538924.7
ENST00000535845.6 |
REEP1
|
receptor accessory protein 1 |
| chr14_-_106062670 | 4.62 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr2_-_86337654 | 4.62 |
ENST00000165698.9
|
REEP1
|
receptor accessory protein 1 |
| chrX_-_54998530 | 4.62 |
ENST00000545676.5
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
| chr8_+_49911396 | 4.58 |
ENST00000642720.2
|
SNTG1
|
syntrophin gamma 1 |
| chr20_+_1266263 | 4.47 |
ENST00000649598.1
ENST00000381867.6 ENST00000381873.7 |
SNPH
|
syntaphilin |
| chr2_-_160200310 | 4.43 |
ENST00000620391.4
|
ITGB6
|
integrin subunit beta 6 |
| chr12_-_48999363 | 4.33 |
ENST00000421952.3
|
DDN
|
dendrin |
| chr14_-_106360320 | 4.31 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr12_+_18262730 | 4.29 |
ENST00000675017.1
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma |
| chr1_+_65992389 | 4.23 |
ENST00000423207.6
|
PDE4B
|
phosphodiesterase 4B |
| chr2_-_210303608 | 4.15 |
ENST00000341685.8
|
MYL1
|
myosin light chain 1 |
| chr2_-_160200289 | 4.13 |
ENST00000409872.1
|
ITGB6
|
integrin subunit beta 6 |
| chr2_+_38666059 | 4.09 |
ENST00000272252.10
ENST00000410063.5 |
GALM
|
galactose mutarotase |
| chr4_+_54229261 | 4.04 |
ENST00000508170.5
ENST00000512143.1 ENST00000257290.10 |
PDGFRA
|
platelet derived growth factor receptor alpha |
| chr4_-_144140683 | 4.04 |
ENST00000324022.14
|
GYPA
|
glycophorin A (MNS blood group) |
| chr11_+_62242232 | 3.98 |
ENST00000244926.4
|
SCGB1D2
|
secretoglobin family 1D member 2 |
| chr6_+_25754699 | 3.98 |
ENST00000439485.6
ENST00000377905.9 |
SLC17A4
|
solute carrier family 17 member 4 |
| chr6_-_27867581 | 3.96 |
ENST00000331442.5
|
H1-5
|
H1.5 linker histone, cluster member |
| chr6_+_31670167 | 3.96 |
ENST00000375864.4
|
LY6G5B
|
lymphocyte antigen 6 family member G5B |
| chr19_+_10430786 | 3.92 |
ENST00000293683.9
|
PDE4A
|
phosphodiesterase 4A |
| chr14_-_106335613 | 3.91 |
ENST00000603660.1
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
| chr17_-_18682262 | 3.91 |
ENST00000454745.2
ENST00000395675.7 |
FOXO3B
|
forkhead box O3B |
| chr1_+_163068775 | 3.86 |
ENST00000421743.6
|
RGS4
|
regulator of G protein signaling 4 |
| chr4_+_95091462 | 3.85 |
ENST00000264568.8
|
BMPR1B
|
bone morphogenetic protein receptor type 1B |
| chr16_+_30375820 | 3.75 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr2_-_160200251 | 3.66 |
ENST00000428609.6
ENST00000409967.6 ENST00000283249.7 |
ITGB6
|
integrin subunit beta 6 |
| chr5_-_32312913 | 3.65 |
ENST00000280285.9
ENST00000382142.8 ENST00000264934.5 |
MTMR12
|
myotubularin related protein 12 |
| chr14_-_106088573 | 3.55 |
ENST00000632099.1
|
IGHV3-64D
|
immunoglobulin heavy variable 3-64D |
| chr14_-_105987068 | 3.47 |
ENST00000390594.3
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr15_-_19988117 | 3.46 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chr6_-_32666648 | 3.29 |
ENST00000399082.7
ENST00000399079.7 ENST00000374943.8 ENST00000434651.6 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
| chr19_-_40750302 | 3.27 |
ENST00000598485.6
ENST00000378313.7 ENST00000470681.5 |
C19orf54
|
chromosome 19 open reading frame 54 |
| chr10_-_1200360 | 3.23 |
ENST00000381310.7
ENST00000381305.1 |
ADARB2
|
adenosine deaminase RNA specific B2 (inactive) |
| chrX_-_32412220 | 3.19 |
ENST00000619831.5
|
DMD
|
dystrophin |
| chr1_+_171314171 | 3.14 |
ENST00000367749.4
|
FMO4
|
flavin containing dimethylaniline monoxygenase 4 |
| chr12_+_6444932 | 3.10 |
ENST00000266557.4
|
CD27
|
CD27 molecule |
| chr19_-_3786408 | 3.09 |
ENST00000395040.6
|
MATK
|
megakaryocyte-associated tyrosine kinase |
| chr4_-_144140635 | 3.09 |
ENST00000512064.5
ENST00000512789.5 ENST00000504786.5 ENST00000503627.2 ENST00000642713.1 ENST00000643148.1 ENST00000642738.1 ENST00000642295.1 ENST00000646447.1 ENST00000535709.6 |
GYPA
|
glycophorin A (MNS blood group) |
| chr13_-_46105009 | 3.08 |
ENST00000439329.5
ENST00000674625.1 ENST00000181383.10 |
CPB2
|
carboxypeptidase B2 |
| chr6_-_166168700 | 3.01 |
ENST00000366871.7
|
TBXT
|
T-box transcription factor T |
| chr9_+_68356899 | 3.00 |
ENST00000396392.5
|
PGM5
|
phosphoglucomutase 5 |
| chr9_-_127847117 | 2.95 |
ENST00000480266.5
|
ENG
|
endoglin |
| chr8_+_24294107 | 2.93 |
ENST00000437154.6
|
ADAM28
|
ADAM metallopeptidase domain 28 |
| chr12_+_32107151 | 2.87 |
ENST00000548411.5
|
BICD1
|
BICD cargo adaptor 1 |
| chr6_-_166168612 | 2.84 |
ENST00000296946.6
|
TBXT
|
T-box transcription factor T |
| chr2_-_73642413 | 2.83 |
ENST00000272425.4
|
NAT8
|
N-acetyltransferase 8 (putative) |
| chr7_+_80638633 | 2.82 |
ENST00000447544.7
ENST00000482059.6 |
CD36
|
CD36 molecule |
| chrX_-_33128360 | 2.75 |
ENST00000378677.6
|
DMD
|
dystrophin |
| chr11_-_84273188 | 2.69 |
ENST00000330014.11
ENST00000418306.6 ENST00000531015.5 |
DLG2
|
discs large MAGUK scaffold protein 2 |
| chr2_-_187554473 | 2.67 |
ENST00000453013.5
ENST00000417013.5 |
TFPI
|
tissue factor pathway inhibitor |
| chr17_+_46511511 | 2.64 |
ENST00000576629.5
|
LRRC37A2
|
leucine rich repeat containing 37 member A2 |
| chr2_+_33476640 | 2.55 |
ENST00000425210.5
ENST00000444784.5 ENST00000423159.5 ENST00000403687.8 |
RASGRP3
|
RAS guanyl releasing protein 3 |
| chr6_+_27957241 | 2.52 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor family 2 subfamily B member 6 |
| chr19_-_3786254 | 2.35 |
ENST00000585778.5
|
MATK
|
megakaryocyte-associated tyrosine kinase |
| chr11_-_66546021 | 2.33 |
ENST00000310442.5
|
ZDHHC24
|
zinc finger DHHC-type containing 24 |
| chr7_+_152759744 | 2.25 |
ENST00000377776.7
ENST00000256001.13 ENST00000397282.2 |
ACTR3B
|
actin related protein 3B |
| chr4_+_118034480 | 2.24 |
ENST00000296499.6
|
NDST3
|
N-deacetylase and N-sulfotransferase 3 |
| chr8_+_49911604 | 2.22 |
ENST00000642164.1
ENST00000644093.1 ENST00000643999.1 ENST00000647073.1 ENST00000646880.1 |
SNTG1
|
syntrophin gamma 1 |
| chr13_+_23979794 | 2.21 |
ENST00000424834.6
ENST00000439928.2 |
SPATA13
SPATA13
|
spermatogenesis associated 13 spermatogenesis associated 13 |
| chr11_+_60455839 | 2.21 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
| chr2_+_225399684 | 2.17 |
ENST00000636099.1
|
NYAP2
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 |
| chr10_-_59753444 | 2.13 |
ENST00000594536.5
ENST00000414264.6 |
MRLN
|
myoregulin |
| chr6_+_122399621 | 2.11 |
ENST00000368455.9
|
HSF2
|
heat shock transcription factor 2 |
| chr19_-_51417619 | 2.07 |
ENST00000441969.7
ENST00000339313.10 ENST00000525998.5 ENST00000436984.6 |
SIGLEC10
|
sialic acid binding Ig like lectin 10 |
| chr7_+_123848070 | 2.06 |
ENST00000476325.5
|
HYAL4
|
hyaluronidase 4 |
| chr4_-_144140712 | 2.05 |
ENST00000641688.3
|
GYPA
|
glycophorin A (MNS blood group) |
| chr8_+_42271289 | 2.05 |
ENST00000520810.6
ENST00000520835.7 |
IKBKB
|
inhibitor of nuclear factor kappa B kinase subunit beta |
| chr4_-_89057156 | 2.03 |
ENST00000511976.5
ENST00000509094.5 ENST00000264344.10 ENST00000515600.1 |
FAM13A
|
family with sequence similarity 13 member A |
| chr3_-_54928044 | 2.02 |
ENST00000273286.6
|
LRTM1
|
leucine rich repeats and transmembrane domains 1 |
| chr12_-_57826295 | 2.01 |
ENST00000549039.5
|
CTDSP2
|
CTD small phosphatase 2 |
| chr4_+_119135825 | 1.99 |
ENST00000307128.6
|
MYOZ2
|
myozenin 2 |
| chr7_+_80638662 | 1.91 |
ENST00000394788.7
|
CD36
|
CD36 molecule |
| chr4_-_144140725 | 1.90 |
ENST00000360771.8
|
GYPA
|
glycophorin A (MNS blood group) |
| chr9_+_68356603 | 1.90 |
ENST00000396396.6
|
PGM5
|
phosphoglucomutase 5 |
| chr7_+_80638510 | 1.85 |
ENST00000433696.6
ENST00000538969.5 ENST00000544133.5 |
CD36
|
CD36 molecule |
| chr12_+_10307950 | 1.85 |
ENST00000543420.5
ENST00000543777.5 |
KLRD1
|
killer cell lectin like receptor D1 |
| chr6_-_42722590 | 1.81 |
ENST00000230381.7
|
PRPH2
|
peripherin 2 |
| chr4_+_40335324 | 1.72 |
ENST00000310169.3
|
CHRNA9
|
cholinergic receptor nicotinic alpha 9 subunit |
| chr11_+_59511539 | 1.69 |
ENST00000641962.1
|
OR4D9
|
olfactory receptor family 4 subfamily D member 9 |
| chr5_+_141330494 | 1.68 |
ENST00000517417.3
ENST00000378105.4 |
PCDHGA1
|
protocadherin gamma subfamily A, 1 |
| chr12_-_9760893 | 1.66 |
ENST00000228434.7
ENST00000536709.1 |
CD69
|
CD69 molecule |
| chr7_-_108240049 | 1.62 |
ENST00000379022.8
|
NRCAM
|
neuronal cell adhesion molecule |
| chr5_-_151224069 | 1.61 |
ENST00000355417.7
|
CCDC69
|
coiled-coil domain containing 69 |
| chrY_+_12662344 | 1.60 |
ENST00000651177.1
|
USP9Y
|
ubiquitin specific peptidase 9 Y-linked |
| chr3_+_113897470 | 1.59 |
ENST00000440446.2
ENST00000488680.1 |
GRAMD1C
|
GRAM domain containing 1C |
| chr16_+_32995048 | 1.57 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
| chr10_-_113664033 | 1.54 |
ENST00000359988.4
ENST00000369360.7 ENST00000360478.7 ENST00000369358.8 |
NRAP
|
nebulin related anchoring protein |
| chr1_+_15684284 | 1.47 |
ENST00000375799.8
ENST00000375793.2 |
PLEKHM2
|
pleckstrin homology and RUN domain containing M2 |
| chr3_+_15003912 | 1.44 |
ENST00000406272.6
ENST00000617312.4 |
NR2C2
|
nuclear receptor subfamily 2 group C member 2 |
| chrX_-_15384402 | 1.42 |
ENST00000297904.4
|
VEGFD
|
vascular endothelial growth factor D |
| chr17_+_34255274 | 1.42 |
ENST00000580907.5
ENST00000225831.4 |
CCL2
|
C-C motif chemokine ligand 2 |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 54.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 3.1 | 15.7 | GO:0072716 | response to actinomycin D(GO:0072716) |
| 3.1 | 12.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 2.9 | 11.7 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 2.8 | 8.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) sarcomerogenesis(GO:0048769) |
| 2.7 | 16.1 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 2.7 | 13.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 2.0 | 16.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 1.9 | 19.1 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 1.9 | 11.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 1.8 | 5.5 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.7 | 5.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of cell fate specification(GO:0009996) |
| 1.6 | 6.2 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.5 | 7.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.5 | 13.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 1.4 | 7.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.4 | 4.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 1.3 | 4.0 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 1.3 | 6.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 1.3 | 5.1 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 1.2 | 6.1 | GO:0090131 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) mesenchyme migration(GO:0090131) |
| 1.2 | 11.6 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.1 | 12.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 1.1 | 12.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 1.0 | 6.1 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) L-ascorbic acid biosynthetic process(GO:0019853) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 1.0 | 14.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.0 | 2.9 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.0 | 14.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 1.0 | 2.9 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 1.0 | 10.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 | 4.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.8 | 3.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.8 | 3.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.7 | 6.6 | GO:2000332 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.7 | 6.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 | 10.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.7 | 6.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.7 | 2.1 | GO:1903347 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.6 | 8.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.6 | 3.9 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.5 | 2.1 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.5 | 6.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.5 | 9.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.5 | 4.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.5 | 31.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.5 | 7.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.5 | 1.4 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.5 | 5.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.5 | 5.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.4 | 5.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 | 1.2 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.4 | 1.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.4 | 35.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.4 | 14.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.4 | 4.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 | 14.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.3 | 10.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.3 | 12.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.3 | 13.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 9.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.3 | 4.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.3 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 6.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.3 | 20.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.2 | 0.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 10.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 | 5.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 5.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 3.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.2 | 19.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.2 | 2.6 | GO:0045794 | response to carbon monoxide(GO:0034465) negative regulation of cell volume(GO:0045794) |
| 0.2 | 3.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.2 | 1.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.2 | 6.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.2 | 32.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 0.7 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.2 | 13.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.2 | 1.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 | 23.8 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.2 | 5.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 4.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 3.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.1 | 7.0 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 2.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 | 5.9 | GO:0061615 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 17.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 6.7 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.1 | 0.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 1.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 | 12.4 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.1 | 1.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 11.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.1 | 6.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.8 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 | 5.4 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
| 0.1 | 5.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 3.0 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 1.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.7 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 14.5 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) |
| 0.1 | 2.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.0 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.0 | 0.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 2.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 | 2.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 1.6 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.0 | 3.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 2.2 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.0 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
| 0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.0 | 2.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 15.1 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.0 | 4.5 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.0 | 2.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 1.7 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.4 | GO:2000828 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 | 1.0 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.0 | 1.8 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
| 0.0 | 4.3 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 1.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 54.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 3.1 | 12.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 2.3 | 7.0 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 2.1 | 14.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 2.0 | 6.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 2.0 | 12.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.5 | 19.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 1.3 | 10.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 1.1 | 12.7 | GO:0016013 | syntrophin complex(GO:0016013) |
| 1.1 | 14.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 1.0 | 2.9 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.9 | 16.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.8 | 10.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.8 | 16.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.7 | 5.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.6 | 31.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.5 | 5.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 21.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.5 | 1.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.5 | 2.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.5 | 6.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.5 | 7.7 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.4 | 7.1 | GO:0043235 | receptor complex(GO:0043235) |
| 0.4 | 9.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.4 | 5.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.3 | 7.8 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.3 | 5.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 11.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 6.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.3 | 3.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 4.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 29.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.3 | 6.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.2 | 4.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 18.1 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 4.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 4.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 6.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 0.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.2 | 2.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 5.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 25.5 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 2.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 44.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 19.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 12.4 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 21.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 42.1 | GO:0009986 | cell surface(GO:0009986) |
| 0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 5.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 2.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 7.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 1.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 6.1 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 11.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 5.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 2.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.0 | 5.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 2.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 4.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 1.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 4.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 5.5 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 1.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 47.2 | GO:0005886 | plasma membrane(GO:0005886) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 9.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 2.9 | 14.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 2.9 | 8.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 1.7 | 10.5 | GO:0070728 | leucine binding(GO:0070728) |
| 1.4 | 7.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.4 | 16.3 | GO:0008430 | selenium binding(GO:0008430) |
| 1.3 | 6.7 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 1.3 | 4.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 1.3 | 6.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.2 | 10.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.2 | 11.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 1.2 | 4.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.1 | 12.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 1.0 | 5.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 1.0 | 12.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.9 | 10.3 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.9 | 13.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.9 | 9.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.8 | 6.6 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.8 | 4.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.7 | 5.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.7 | 5.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.7 | 2.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.7 | 6.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.6 | 24.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.6 | 19.1 | GO:0005521 | lamin binding(GO:0005521) |
| 0.6 | 54.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.6 | 10.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.6 | 10.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.6 | 2.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 31.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.5 | 6.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.5 | 15.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.5 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.5 | 2.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 3.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.4 | 6.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.4 | 4.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.4 | 6.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.4 | 4.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.4 | 5.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.4 | 2.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.4 | 2.9 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 35.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.3 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.3 | 5.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.3 | 3.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 29.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.3 | 2.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.3 | 2.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.3 | 2.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.3 | 11.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.3 | 1.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.3 | 4.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.3 | 9.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.3 | 47.7 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 10.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 23.3 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.2 | 5.3 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.2 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 13.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 8.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 5.4 | GO:0070034 | telomerase RNA binding(GO:0070034) DNA polymerase binding(GO:0070182) |
| 0.2 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.1 | 1.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 4.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 2.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 1.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 1.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.1 | 3.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 3.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.5 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.1 | 15.1 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 3.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 17.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 2.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 11.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 9.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 1.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 22.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 2.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 1.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 1.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 4.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 4.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.0 | 12.4 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.0 | 3.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 10.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.0 | 12.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.0 | 1.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 2.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.0 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 5.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 3.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 2.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 54.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.5 | 12.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 13.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.3 | 5.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.3 | 12.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 11.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.2 | 13.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 5.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 4.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 18.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.2 | 10.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 9.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 23.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.2 | 11.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 10.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 4.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 13.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 4.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 12.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 9.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 7.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 5.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 5.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 5.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 5.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 5.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 7.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 10.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.9 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 2.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 1.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 54.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 1.9 | 11.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.7 | 12.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.7 | 6.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.5 | 10.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 19.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.4 | 35.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.4 | 19.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.4 | 11.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 14.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 11.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 7.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 13.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.3 | 31.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.2 | 5.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 5.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 7.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 4.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 10.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 18.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 10.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 6.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 6.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 4.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.1 | 5.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 9.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 12.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 4.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 6.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 10.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 3.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 4.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 6.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 7.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.9 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
| 0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 2.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 0.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 1.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |